"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II st...

by Bruera, Gemma, Santomaggio, Alessandra, Cannita, Katia, Baldi, Paola Lanfiuti, Tudini, Marianna, De Galitiis, Federica, Mancini, Maria, Marchetti, Paolo, Antonucci, Adelmo, Ficorella, Corrado, Ricevuto, Enrico
Published 2010

Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis

by Cocciolone, Valentina, Cannita, Katia, Calandrella, Maria Letizia, Ricevuto, Enrico, Baldi, Paola Lanfiuti, Sidoni, Tina, Irelli, Azzurra, Paradisi, Stefania, Pizzorno, Laura, Resta, Valter, Bafile, Alberto, Alesse, Edoardo, Tessitore, Alessandra, Ficorella, Corrado
Published in Oncotarget (2017)

Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations

by Cocciolone, Valentina, Cannita, Katia, Tessitore, Alessandra, Mastroiaco, Valentina, Rinaldi, Lucia, Paradisi, Stefania, Irelli, Azzurra, Baldi, Paola Lanfiuti, Sidoni, Tina, Ricevuto, Enrico, Dal Mas, Antonella, Calvisi, Giuseppe, Coletti, Gino, Ciccozzi, Antonietta, Pizzorno, Laura, Resta, Valter, Bafile, Alberto, Alesse, Edoardo, Ficorella, Corrado
Published in Oncotarget (2018)